Diagnostic Challenges in Hematopathology
Hematopoietic neoplasms are highly heterogeneous, composed of numerous clinicopathologic subtypes and variants, and may present at many organ sites. The diagnostic evaluation of lymphomas and hematopoietic neoplasms presenting at nodal and extra-nodal sites requires careful integration of histologic, immunophenotypic, clinical and molecular features. Furthermore, rapid advances in the genetic/genomic understanding of these diseases pose a significant challenge to staying abreast of the diagnostic criteria, immunophenotypic and molecular prognostic/therapeutic markers that have clinical impact. This is underscored by diminishing sample sizes in biopsies of extra-nodal lesions and needle core biopsies of lymph nodes. In addition, the role of the pathologist as integrators of information is expanding rapidly.
This educational activity will highlight practical aspects representing important changes that impact the diagnostic approach to challenging extra-nodal hematopoietic neoplasms, cutaneous lymphomas, T-cell lymphomas and needle core biopsies from lymph nodes. Experience one-on-one learning from experts who will share their varied and profound experience in an aesthetic and dynamic venue, recalling the clinical sign-out of your training years.
Course Location: Palm Springs, CA
Course Director: Megan S. Lim, M.D., Ph.D.
The introduction to Cancer Cytopathology's inaugural Supplement (Volume 125/Issue 6/June 2017) leads with the concept that cytopathology is the nexus for patient-centered care. The convergence of minimally invasive diagnostic and therapeutic techniques, refinements in imaging and guided biopsies, molecular testing and whole genome sequencing, the emergence of targeted therapies, and the awakening of pathologists to their critical role in patient care, safety and outcomes have created a new force in medicine: pathologists are critical members of the health care team and patients are at the center of their concerns and efforts.
Immersive Cytopathology Experience (ICE) has been redesigned for presentation at a fabulous venue in Reykjavik, Iceland, combining concepts from Diagnostic Cytopathology and classical ICE (a hands-on learning experience at the USCAP Interactive Learning Center). There is monumental value in case-based learning that simulates multidisciplinary collaborative interaction of hospital-based tumor boards. This program is highlighted by the interaction of interventional cytopathologists with a surgeon, exemplary patient, and challenging cases from academic institutions, focusing on head and neck clinical lesions.
Classification schemes, the molecular and genetic basis of head and neck disease, procedural approaches to specimen acquisition and processing, empathetic communication, quality and patient safety, and measuring the non-clinical performance of the academic pathologist contribute texture and depth to this learning experience. The schedule accommodates time for you to experience ICELAND, from The Blue Lagoon to the Northern Lights and locations where Game of Thrones is filmed. USCAP is transforming how we learn and where we learn. From a 15th century convent in Florence to the Harpa Concert Hall and Conference Centre in Iceland, learners "come from away" for their unique and enduring experience.